Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study - Wang, Shujie; Ren, Huahui; Zhong, Huanzi; Zhao, Xinjie; Li, Changkun; Ma, Jing; Gu, Xuejiang; Xue, Yaoming; Huang, Shan; Yang, Jialin; Chen, Li; Chen, Gang; et al. (Gut microbes, 2022)
Keywords: Adult; Animals; berberine; Berberine - administration & dosage; Cholesterol - blood; Cholesterol, LDL - blood; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - microbiology; Double-Blind Method; Drug Therapy, Combination; dyslipidemia; Feces - microbiology; Female; Gastrointestinal Microbiome - drug effects; gut microbiome; Humans; Hyperlipidemias - blood; Hyperlipidemias - drug therapy; Hyperlipidemias - microbiology; Male; Middle Aged; postprandial lipidemia; Postprandial Period - drug effects; probiotics; Probiotics - administration & dosage; Research Paper; Type 2 diabetes; Type 2 diabetes; gut microbiome; dyslipidemia; postprandial lipidemia; berberine; probiotics